Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose IL-2 in Relapsing Polychondritis
NCT04077736Phase 2Completed
- Sponsor
- Peking University People's Hospital
- Start
- Nov 2019
- Primary completion
- Oct 2023
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in relapsing polychondritis (RP), sponsored by Peking University People's Hospital. Started Nov 2019; status: completed.
02
Drugs
aldesleukin
03
Conditions
relapsing polychondritis (RP)
Beyond the preview
Go deeper on NCT04077736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04077736.